ALLMedicine™ Acne Vulgaris Center
Research & Reviews 982 results
https://doi.org/10.1111/jocd.14359
Journal of Cosmetic Dermatology; Slutsky-Bank E, Artzi O et. al.
Aug 2nd, 2021 - Photodynamic therapy (PDT) is considered an effective treatment for acne vulgaris. A significant drawback is pain during illumination. Daylight PDT (DL-PDT) is more tolerable. To assess and compare the efficacy and tolerability of DL-PDT and C-PDT...
https://doi.org/10.1111/jocd.14281
Journal of Cosmetic Dermatology; Calvisi L
Jul 29th, 2021 - Acne vulgaris is a common skin condition affecting the pilosebaceous unit of the skin characterized by the presence of comedones, papules, pustules, nodules, and cysts, which might result in permanent scars. It commonly affects adolescents, but it...
https://doi.org/10.1080/15321819.2021.1952425
Journal of Immunoassay & Immunochemistry; Bazid BASE, Marae A et. al.
Jul 23rd, 2021 - Numerous cytokines are involved in acne vulgaris pathogenesis, though few studies correlate interleukin IL-19 to acne vulgaris. So this study aimed to assess the IL-19 (rs 2243191) gene polymorphism and its serum level in acne vulgaris. This case-...
https://doi.org/10.1007/s40257-021-00624-5 10.1111/bjd.12149 10.1001/jamadermatol.2020.0464 10.1016/j.jaad.2015.12.037 10.1016/j.jaad.2020.02.040 10.2165/00128071-200102030-00002 10.1002/lsm.20276 10.1007/s10103-017-2294-7 10.1067/mjd.2001.113717 10.1177/1203475420928904 10.1111/jdv.14881 10.2165/11598910-000000000-00000 10.1002/lsm.22410 10.1111/j.1524-4725.2012.02572.x 10.1002/lsm.20405 10.1002/lsm.20802 10.1111/ced.12010 10.1002/der2.9 10.3109/14764172.2012.720023 10.1111/jocd.12207 10.1016/j.sder.2005.04.001 10.1097/00042728-200510000-00005 10.3109/14764172.2011.630087 10.1080/14764170902741329 10.1111/j.1365-2133.2006.07429.x 10.1111/j.1473-2165.2010.00483.x 10.1111/ijd.13631 10.1111/j.1365-2133.2010.09806.x 10.1097/DSS.0000000000000658 10.15171/jlms.2015.13 10.1080/09546630701646164 10.3109/14764172.2013.854626 10.1007/s40257-020-00530-2 10.1016/j.arthe.2014.08.003 10.4328/ACAM.20039 10.1016/j.jaad.2011.08.031 10.1111/j.1524-4725.2010.01643.x 10.1097/DSS.0000000000001565 10.1111/jocd.13278 10.1111/jocd.13480 10.1016/j.jaad.2006.02.018 10.1111/j.1524-4725.2009.01097.x 10.1111/j.1365-2133.2011.10614.x 10.1111/jdv.14714 10.1097/DSS.0000000000000167 10.1007/s10103-016-1871-5 10.1097/DSS.0000000000001546 10.1001/jamadermatol.2017.2077 10.1007/s10103-015-1816-4 10.1038/jid.2015.89 10.1002/lsm.23099 10.1515/znc-1987-1-220 10.3109/14764172.2011.630081 10.1002/lsm.1900090513 10.1111/j.1365-2133.2009.09047.x 10.4103/0019-5154.94283 10.1142/S1793545811001241 10.4103/0378-6323.104673 10.1111/bjd.12186 10.1080/14764172.2016.1247961 10.1111/phpp.12098 10.1111/jocd.13586 10.1111/j.1524-4725.2009.01380.x 10.4103/0019-5154.74550 10.4103/0019-5154.190115 10.1080/14764172.2019.1605450 10.5021/ad.2011.23.1.23 10.1111/jocd.13197 10.1007/s10103-020-03113-z 10.1016/j.pdpdt.2013.06.007 10.5978/islsm.14-OR-09 10.1111/1346-8138.12836 10.1111/phpp.12059 10.1016/j.jaad.2020.04.146 10.1007/s12013-015-0627-3 10.1016/j.pdpdt.2010.01.003 10.2147/CCID.S227737 10.1111/j.1365-2133.2010.09860.x 10.1111/jocd.13038 10.1177/120347541201600509 10.1016/j.jaad.2014.05.047 10.5021/ad.2012.24.1.56 10.1111/j.1365-2133.2011.10472.x 10.1007/s10103-016-2029-1 10.1002/lsm.20886 10.1016/j.pdpdt.2015.06.007 10.1111/phpp.12031 10.1007/s00403-016-1639-6 10.5978/islsm.12-OR-07 10.4103/2229-5178.156379 10.5021/ad.2012.24.3.280 10.3109/14764172.2013.814464
American Journal of Clinical Dermatology; Li MK, Liu C et. al.
Jul 22nd, 2021 - Acne vulgaris is a disease of the pilosebaceous unit and the most common inflammatory dermatosis worldwide. It is also associated with significant economic burden. Limitations of conventional topical and systemic treatments include long treatment ...
https://doi.org/10.1007/s00403-021-02267-2 10.1111/pde.12802 10.3109/21691401.2014.916715 10.1111/j.1346-8138.2011.01405.x 10.1016/j.jaad.2009.07.052 10.3109/03639045.2012.671829 10.1016/j.ijpharm.2007.05.061 10.1016/j.ijpharm.2008.06.028 10.1016/j.ijpharm.2006.08.007 10.1007/s11095-006-9225-9 10.1016/j.ejpb.2011.01.017 10.3109/10837450.2015.1078353 10.1080/02652048.2017.1316324 10.1016/j.ejps.2018.04.029 10.7860/JCDR/2015/10663.5469 10.4103/0378-6323.30646 10.1016/j.jadohealth.2008.06.005 10.1016/j.ijantimicag.2014.10.011 10.1021/mp300722f 10.1016/j.jaad.2004.10.879 10.1111/jdv.12823 10.4103/0378-6323.98077 10.1016/S1054-139X(97)00277-2
Archives of Dermatological Research; Najafi-Taher R, Jafarzadeh Kohneloo A et. al.
Jul 13th, 2021 - Adapalene is used for treatment of acne vulgaris, a common dermatological disease. Nano-based carriers have been developed to improve solubility and bioavailability of adapalene and other acne treatment drugs. In our previous report, tea tree oil ...
Guidelines 2 results
https://doi.org/10.1111/1346-8138.14355
The Journal of Dermatology; Hayashi N, Akamatsu H et. al.
May 22nd, 2018 - The Guidelines for the Treatment of Acne Vulgaris of the Japanese Dermatological Association was first published in Japanese in 2008 and revised in 2016 and 2017. These guidelines (GL) indicate the standard acne treatments in Japan and address pha...
https://doi.org/10.1542/peds.2013-0490B
Pediatrics Eichenfield LF, Krakowski AC et. al.
May 3rd, 2013 - Acne vulgaris is one of the most common skin conditions in children and adolescents. The presentation, differential diagnosis, and association of acne with systemic pathology differs by age of presentation. Current acknowledged guidelines for the ...
Drugs 360 results see all →
Clinicaltrials.gov 155 results
https://clinicaltrials.gov/ct2/show/NCT03664739
Apr 3rd, 2020 - This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel at Weeks 2, 4, 8, and 12. To be eligible for the study subjects mu...
https://clinicaltrials.gov/ct2/show/NCT03271021
Mar 9th, 2020 - This is a randomized, multicenter, double-blind, vehicle-controlled, 2 arm study to evaluate the safety and efficacy over 12 weeks of FMX101 topical foam containing 4% minocycline compared to vehicle in the treatment of subjects with moderate-to-s...
https://clinicaltrials.gov/ct2/show/NCT03334682
Feb 26th, 2020 - Acne vulgaris of adult woman has increased over the past 10 years; it affects currently 20% to 30% of adult women. The physiopathology of adult woman acne is distinguished from the teenager one by essentially 2 factors: hormonal factor with a peri...
https://clinicaltrials.gov/ct2/show/NCT02431494
Feb 24th, 2020 - Overview: The goal of this study is to conduct a small randomized control trial (RCT) to test the safety and preliminary efficacy of a novel combination therapy to treat acne vulgaris. The investigators will also explore the effects of the treatme...
https://clinicaltrials.gov/ct2/show/NCT01320033
Feb 10th, 2020 - Investigator's global assessment and lesion count will be performed at each study visit.
News 151 results
https://www.medscape.com/viewarticle/953824
Jun 28th, 2021 - The National Institute for Health and Care Excellence (NICE) has recommended that individuals severely affected by acne should receive mental health support in a new guideline on the management of acne vulgaris published on 25 June 2021. An estima...
https://www.medscape.com/viewarticle/951545
May 20th, 2021 - Of the dermatologic indications for radiofrequency microneedling (RFMN), the published evidence is strongest for skin rejuvenation, acne vulgaris, acne scars, and axillary hyperhidrosis, according to results from a new systematic review. "Most dev...
https://www.medscape.com/viewarticle/938835
Oct 8th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. During the virtual annual Masters of Aesthetics Symposium, he highlighted the foll...
https://www.staging.medscape.com/viewarticle/938835
Oct 8th, 2020 - In the opinion of Lawrence F. Eichenfield, MD, recent advances in the medical treatment of acne make it "an exciting time" for treating patients with the condition. During the virtual annual Masters of Aesthetics Symposium, he highlighted the foll...
https://www.medscape.com/viewarticle/936427
Aug 27th, 2020 - The Food and Drug Administration has approved clascoterone 1% cream for the topical therapy of acne, providing a treatment with a novel mechanism of action for acne. Clascoterone is a topical androgen receptor inhibitor indicated for treatment of ...
